Department of Pathology & Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States.
Department of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Semin Diagn Pathol. 2023 Jul;40(4):295-305. doi: 10.1053/j.semdp.2023.04.018. Epub 2023 Apr 25.
Cutaneous (myo)fibroblastic tumors constitute a group of tumors with overlapping clinicopathological features and variable biologic behavior. In the present review we focus on the histomorphology, immunohistochemical profile and molecular background of the following entities: dermatofibrosarcoma protuberans (DFSP), CD34-positive fibroblastic tumor (SCD34FT), myxoinflammatory sarcoma (MIFS), low-grade myofibroblastic sarcoma, solitary fibrous tumor and nodular fasciitis. Although some of these entities typically arise in deep-seated locations, they may occasionally present as cutaneous/superficial tumors and might be challenging to recognize. This review covers in depth the latest advances in molecular diagnostics and immunohistochemical markers that have significantly facilitated the correct classification and diagnosis of these neoplasms.
皮肤(肌)纤维母细胞瘤是一组具有重叠临床病理特征和不同生物学行为的肿瘤。在本综述中,我们重点关注以下实体的组织形态学、免疫组织化学特征和分子背景:隆突性皮肤纤维肉瘤(DFSP)、CD34 阳性纤维母细胞瘤(SCD34FT)、黏液炎症性肉瘤(MIFS)、低度肌纤维母细胞瘤肉瘤、孤立性纤维性肿瘤和结节性筋膜炎。尽管其中一些实体通常起源于深部位置,但它们偶尔也可能表现为皮肤/表浅肿瘤,并且可能难以识别。本综述深入探讨了分子诊断和免疫组织化学标志物的最新进展,这些进展极大地促进了这些肿瘤的正确分类和诊断。